The ground shook for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) last week as the U.S. Food and Drug Administration (FDA), ...

Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous ...

From a regulatory perspective, I would like to highlight the following major challenges. Firstly, the fast pace of innovation in drug development for rare diseases creates challenges for regulators, ...